SEC Comment Letter for Ernexa Therapeutics Inc. (ERNA, ERNAW) (CIK 0000748592) (ERNA) — Jan 19, 2017
Ernexa Therapeutics Inc. (ERNA, ERNAW) (CIK 0000748592)
Date: Jan. 19, 2017 · CIK: 0000748592 · Accession: 0000000000-17-002099
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 001-11460
Letter
Mail Stop 3720 January 19, 20 17 Sandra Gurrola Vice President of Finance NTN Buzztime, Inc. 2231 Rutherford Rd., Suite 200 Carlsbad, CA 92008
Re: NTN Buzztime, Inc. Form 10 -K for Fiscal Year Ended December 31, 2015 Filed March 27, 2016 File No. 001-11460
Dear Ms. Gurrola :
We have comple ted our review of your filing . We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosure s, notwithstanding any review, comments, action or absence of action by the staff .
Sincerely,
/s/ Larry Spirgel
Show Raw Text
Mail Stop 3720 January 19, 20 17 Sandra Gurrola Vice President of Finance NTN Buzztime, Inc. 2231 Rutherford Rd., Suite 200 Carlsbad, CA 92008 Re: NTN Buzztime, Inc. Form 10 -K for Fiscal Year Ended December 31, 2015 Filed March 27, 2016 File No. 001-11460 Dear Ms. Gurrola : We have comple ted our review of your filing . We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosure s, notwithstanding any review, comments, action or absence of action by the staff . Sincerely, /s/ Larry Spirgel Larry Spirgel Assistant Director AD Office 11 – Telecommunications Cc: Edwin Astudillo Breakwater Law Group